source
- Regeneron secures first FDA approval for gene therapy treating rare inherited hearing lossRegeneron announced that the U.S. Food and Drug Administration has approved its gene-based treatment Otarmeni, marking the first approval of a therapy for inherited hearing loss. The therapy is de…
- Novo Nordisk's GLP-1 pill shows blood-sugar reduction in teens with type 2 diabetesNovo Nordisk reported results from a study evaluating its oral GLP-1 therapy, Rybelsus, in adolescents with type 2 diabetes. The trial enrolled participants aged 10-17 who took the pill for roughl…